Increased D-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study
about
Therapeutic Targets for Neurodevelopmental Disorders Emerging from Animal Models with Perinatal Immune ActivationFunctional alterations of astrocytes in mental disorders: pharmacological significance as a drug targetIn vivo magnetic resonance studies reveal neuroanatomical and neurochemical abnormalities in the serine racemase knockout mouse model of schizophrenia.A novel pyridoxal 5'-phosphate-dependent amino acid racemase in the Aplysia californica central nervous system.Reduced cortical thickness is associated with the glutamatergic regulatory gene risk variant DAOA Arg30Lys in schizophrenia.d-amino acid oxidase knockout (Dao(-/-) ) mice show enhanced short-term memory performance and heightened anxiety, but no sleep or circadian rhythm disruption.D-serine as a gliotransmitter and its roles in brain development and disease.Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis.D-serine and schizophrenia: an update.D-Amino acids in the brain and mutant rodents lacking D-amino-acid oxidase activity.Elucidating the role of the pLG72 R30K substitution in schizophrenia susceptibility.Expression of D-Amino Acid Oxidase (DAO/DAAO) and D-Amino Acid Oxidase Activator (DAOA/G72) during Development and Aging in the Human Post-mortem Brain.Serine enantiomers as diagnostic biomarkers for schizophrenia and bipolar disorder.Decreased reelin expression in the left prefrontal cortex (BA9) in chronic schizophrenia patients.Effects of low-dose D-serine on recognition and working memory in mice.DAOA variants and schizophrenia: influence on diagnosis and treatment outcomes.Biochemical Properties of Human D-amino Acid Oxidase Variants and Their Potential Significance in Pathologies.
P2860
Q26775092-FBAEB323-CAEE-4C24-AC55-410D075EEA4BQ26798948-4266A55E-E2FF-42E3-8B07-E88F946D08EAQ30873588-F77A80F7-3B34-4BDD-96A7-A142F6A2DBA7Q34787491-FB0F0FBA-531C-45B8-8405-58C39F031204Q35112156-38EC78E7-5E80-4FA6-806C-835534857952Q36554272-13703928-56FA-445B-BB3D-6238F7E2DC32Q36785486-4669DF85-90CD-4432-A51E-B081796DA566Q36955877-D386F26C-B58C-49F4-859D-74ABD8FB54FDQ38031285-611AF184-2E35-48A1-8EB7-88E6DFBB6771Q38034652-5ACEA2B8-D3C1-4EFF-8FE2-B23F7EC4BF2FQ38717701-E1007E94-0E4A-437E-8015-B267D681E5CFQ42107408-79C64045-1A6E-4E29-8F88-34F06B616D3FQ47706465-A3A9518F-7640-41FC-96EF-743C84B9AA0BQ48439765-AE3A8E39-668B-4B35-9335-D03FB6585359Q51009647-01228A08-1BA5-45F7-A0ED-84AB9C04CBBBQ53396523-00E76440-1660-49D8-ADDF-32289A761183Q55340063-96BB7FAB-C779-4E67-A535-2E88D602E947
P2860
Increased D-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Increased D-amino acid oxidase ...... patients: a post-mortem study
@en
Increased D-amino acid oxidase ...... patients: a post-mortem study.
@nl
type
label
Increased D-amino acid oxidase ...... patients: a post-mortem study
@en
Increased D-amino acid oxidase ...... patients: a post-mortem study.
@nl
prefLabel
Increased D-amino acid oxidase ...... patients: a post-mortem study
@en
Increased D-amino acid oxidase ...... patients: a post-mortem study.
@nl
P2093
P2860
P50
P1476
Increased D-amino acid oxidase ...... patients: a post-mortem study
@en
P2093
Fritz A Henn
Georg Petroianu
Gregor Habl
Manfred Bauer
Martina von Wilmsdorff
Mathias Zink
P2860
P2888
P304
P356
10.1007/S00702-009-0312-Z
P577
2009-10-13T00:00:00Z